-

Seven Hills Capital Announces Close of Sophomore Fund at $235 Million Hard Cap

NASHVILLE, Tenn.--(BUSINESS WIRE)--Seven Hills Capital (“SHC” or “Seven Hills”) is proud to announce the first-and-final closing of its oversubscribed sophomore fund, Seven Hills Capital Fund II, L.P., quietly reaching its $235 million hard cap in less than three months. The closing comes just two years after the successful $125 million fundraising of Seven Hills Capital Fund I.

Seven Hills Capital Announces Close of Sophomore Fund at $235 Million Hard Cap

Share

Founded in 2016, Seven Hills is an operator-centric lower middle market private equity firm focused on thematic niches within healthcare services. Drawing on experience as both operators and investors, the team works alongside its Partner Companies and CEOs, taking a hands-on approach to building durable businesses that improve outcomes for patients, payors, and providers.

A defining element of SHC’s model is its Strategic Performance Group (“SPG”) -- an internal operating team built to accelerate Partner Company development by enhancing operational systems and growth levers. The SPG team supports revenue cycle management, financial reporting, system conversions, acquisition integration, strategic planning, and de novo growth. “We built SPG to bring institutional-level resources to entrepreneurial businesses -- without losing the culture that made them successful. Nashville’s vibrant healthcare and entrepreneurial ecosystem has allowed SPG to be built with local subject matter experts working alongside SHC’s investment team and Partner Companies,” said Matthew Pettit, Seven Hills’ Founder.

Fund II attracted capital from a diverse group of highly respected institutional limited partners, including prestigious college and university endowments, mission driven foundations, single and multi-family offices, and outsourced CIOs. “We are humbled to have received such strong support from new and existing investors who share our enthusiasm for building best-in-class healthcare businesses,” said Pettit.

Pacenote Capital LLC served as Seven Hills’ exclusive placement agent for both Fund I and II. Pettit continued, “We are grateful for the outstanding work by Pacenote, both in identifying exceptional long-term investors to support our mission and for their conviction in us as investors.”  

McGuireWoods LLP provided legal counsel in connection with the fundraising.

Contacts

For more information or inquiries, please visit www.7hillscap.com or contact Sydney Wracher sydney@7hillscap.com

Seven Hills Capital


Release Versions

Contacts

For more information or inquiries, please visit www.7hillscap.com or contact Sydney Wracher sydney@7hillscap.com

More News From Seven Hills Capital

Seven Hills Capital Announces Platform Investment in Infusion Therapy through Partnership with Market Leading CPS Infusion

ATLANTA & NASHVILLE, Tenn.--(BUSINESS WIRE)--Seven Hills Capital is thrilled to announce its partnership with CPS Infusion (“CPS”) and platform investment in Infusion Therapy. The Partnership was formed in August 2025 and is poised to continue its growth plan in target markets. Greater Atlanta, GA based CPS Infusion provides best-in-class outpatient infusion therapy for rare and chronic disease patients. CPS was founded by Dr. Marcus Crawford and has grown to seven locations across Greater Atla...

Spa Medicca Enhances Footprint in Ohio and Expands Service Offering by Partnering with Amy Brenner, MD & Associates

NASHVILLE, TN & CINCINNATI, OH--(BUSINESS WIRE)--Spa Medicca is excited to announce its partnership with Amy Brenner, MD & Associates. Partnering with Dr. Brenner and her team further establishes Spa Medicca as the premier aesthetics and wellness business in greater Cincinnati. Amy Brenner, MD & Associates brings industry expertise as well as new hormone replacement therapy and sexual wellness services to the Spa Medicca patient base. Dr. Amy Brenner, owner of Amy Brenner, MD and Associ...
Back to Newsroom